Mildronate Meldonium 500mg 60 capsules

Mildronate Composition:
active ingredient: meldonium; 1 hard capsule contains 500 mg of meldonium;
excipients: potato starch, silicon dioxide, calcium stearate; capsule (body and cap): titanium dioxide (E 171), gelatin.

Pharmacotherapeutic group: Other cardiac drugs. ATX code C01E B22.

Indications:
In complex therapy in the following cases: diseases of the heart and vascular system: stable angina pectoris, chronic heart failure (NYHA I-III functional class), cardiomyopathy, functional disorders of the heart and vascular system; acute and chronic ischemic cerebrovascular accidents reduced performance, physical and psycho-emotional overstrain; during the recovery period after cerebrovascular disorders, head injuries and encephalitis.

Dosage and administration:
Take orally before or after meals. The capsule is swallowed with water. Due to the possible stimulating effect, the drug is recommended to be used in the morning.

adults
Diseases of the heart and circulatory system, disorders of cerebral circulation The daily dose is 500-1000 mg, you can use the entire dose at one time or distribute it into 2 doses. The maximum daily dose is 1000 mg. With reduced performance, overstrain, during the recovery period The daily dose is 500 mg. The maximum daily dose is 500 mg. The duration of the course of treatment is 4-6 weeks. The course of treatment can be repeated 2-3 times a year.

Elderly patients
For elderly patients with impaired liver and / or kidney function, it may be necessary to reduce the dose of meldonium. Patients with impaired renal function Since the drug is excreted from the body by the kidneys, patients with mild to moderate renal impairment should use a lower dose of meldonium.

Patients with impaired liver function
Patients with mild to moderate hepatic impairment should use a lower dose of meldonium.

Produced in Latvia